Updates are available Correction dated 2021-10-09
Click to view Correction: https://doi.org/10.1186/s13075-021-02639-z
-
Authors
Marklein, Bianka
Jenning, Madeleine
Konthur, Zoltán
Häupl, Thomas
Welzel, Franziska
Nonhoff, Ute
Krobitsch, Sylvia
Mulder, Debbie M.
Koenders, Marije I.
Joshua, Vijay
Cope, Andrew P.
Shlomchik, Mark J.
Anders, Hans-Joachim
Burmester, Gerd R.
Hensvold, Aase
Catrina, Anca I.
Rönnelid, Johan
Steiner, Günter
Skriner, Karl http://orcid.org/0000-0002-5415-270X
-
Funding
Funding for this research was provided by:
ArthroMark (01EC1401A)
ProgRATE (0315941C)
BTCure (115142-2)
tIVDiRA FKZ (13GW0194CA)
RTCure (777357)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 25 May 2021
Accepted: 6 August 2021
First Online: 14 September 2021
Change Date: 9 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13075-021-02639-z
Declarations
:
: The study has been performed in compliance with the Declaration of Helsinki, with informed consent obtained from all study participants, and ethical approval granted at the Regional Ethical Review Board in Berlin, Erlangen, Vienna, and Stockholm.
: Not applicable
: The authors declare that they have no conflicting financial interest and have not received funding from commercial sources in the context of this study. KS and ZK are co-inventors of the patent WO/2010/072673 Diagnostic Prediction of Rheumatoid Arthritis and Systemic Lupus Erythematosus, protecting the use of the hnRNP-DL and cit-hnRNP-DL in RA and SLE.
